Literature DB >> 2056258

The fifth nonlethal case of primary amoebic meningoencephalitis.

N Poungvarin1, P Jariya.   

Abstract

The fifth nonlethal case of primary amoebic meningoencephalitis was reported. He was a 61-year-old gardener from northeast Thailand who had an abrupt onset of high fever, headache and stupor. Lumbar puncture showed numerous naegleria in the cerebrospinal fluid. The combination of 0.5 mg/kg/day of intravenous amphotericin B for 14 days, oral rifampicin and oral ketoconazole for 1 month cured the patient with no recurrence after one year of follow-up. The authors emphasise the regimen of low dose amphotericin B for a prolonged period instead of a high dose over a short period.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056258

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  14 in total

1.  Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Soltow; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

2.  Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.

Authors:  Jong-Hyun Kim; Suk-Yul Jung; Yang-Jin Lee; Kyoung-Ju Song; Daeho Kwon; Kyongmin Kim; Sun Park; Kyung-Il Im; Ho-Joon Shin
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

Review 3.  Review of clinical presentations in Thai patients with primary amoebic meningoencephalitis.

Authors:  Viroj Wiwanitkit
Journal:  MedGenMed       Date:  2004-03-08

4.  Scanning electron microscopic study of human neuroblastoma cells affected with Naegleria fowleri Thai strains.

Authors:  Supathra Tiewcharoen; Jundee Rabablert; Pruksawan Chetanachan; Virach Junnu; Dusit Worawirounwong; Nat Malainual
Journal:  Parasitol Res       Date:  2008-08-07       Impact factor: 2.289

5.  Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Goswick; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

6.  Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and Its Synergistic Effect with Amphotericin B In Vitro.

Authors:  Jose Ignacio Escrig; Hye Jee Hahn; Anjan Debnath
Journal:  ACS Chem Neurosci       Date:  2020-05-26       Impact factor: 4.418

7.  Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.

Authors:  Anjan Debnath; Josefino B Tunac; Silvia Galindo-Gómez; Angélica Silva-Olivares; Mineko Shibayama; James H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

8.  Naegleria fowleri after 50 years: is it a neglected pathogen?

Authors:  Moisés Martínez-Castillo; Roberto Cárdenas-Zúñiga; Daniel Coronado-Velázquez; Anjan Debnath; Jesús Serrano-Luna; Mineko Shibayama
Journal:  J Med Microbiol       Date:  2016-07-04       Impact factor: 2.472

9.  The immune response induced by DNA vaccine expressing nfa1 gene against Naegleria fowleri.

Authors:  Jong-Hyun Kim; Sang-Hee Lee; Hae-Jin Sohn; Jinyoung Lee; Yong-Joon Chwae; Sun Park; Kyongmin Kim; Ho-Joon Shin
Journal:  Parasitol Res       Date:  2012-09-07       Impact factor: 2.289

10.  Diagnosis of infections caused by pathogenic free-living amoebae.

Authors:  Bruno da Rocha-Azevedo; Herbert B Tanowitz; Francine Marciano-Cabral
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.